Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Short-term Investments: 2011-2013

  • Fennec Pharmaceuticals' Short-term Investments was N/A to $22.8 million in Q4 2013 from the same period last year, while for Dec 2013 it was $22.8 million, marking a year-over-year change of. This contributed to the annual value of $22.8 million for FY2013, which is N/A change from last year.
  • As of Q4 2013, Fennec Pharmaceuticals' Short-term Investments stood at $22.8 million, which was down 0.00% from $22.8 million recorded in Q1 2011.
  • Over the past 5 years, Fennec Pharmaceuticals' Short-term Investments peaked at $22.8 million during Q1 2011, and registered a low of $22.8 million during Q1 2011.
  • Moreover, its 2-year median value for Short-term Investments was $22.8 million (2013), whereas its average is $22.8 million.